APA Alıntı

Villalobos, M., Czapiewski, P., Reinmuth, N., Fischer, J. R., Andreas, S., Kortsik, C., . . . Thomas, M. (2019). Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab. Oncol Lett.

Chicago Stili Alıntı

Villalobos, Matthias, et al. "Impact of EMT in Stage IIIB/IV NSCLC Treated With Erlotinib and Bevacizumab When Compared With Cisplatin, Gemcitabine and Bevacizumab." Oncol Lett 2019.

MLA Alıntı

Villalobos, Matthias, et al. "Impact of EMT in Stage IIIB/IV NSCLC Treated With Erlotinib and Bevacizumab When Compared With Cisplatin, Gemcitabine and Bevacizumab." Oncol Lett 2019.